Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celldex Therapeutics (CLDX) Amortization of Goodwill (2018)

Celldex Therapeutics (CLDX) has 1 years of Amortization of Goodwill data on record, last reported at -$24000.0 in Q2 2018.

  • For Q2 2018, Amortization of Goodwill changed N/A year-over-year to -$24000.0; the TTM value through Dec 2018 reached $91.0 million, changed N/A, while the annual FY2018 figure was $91.0 million, N/A changed from the prior year.
  • Amortization of Goodwill reached -$24000.0 in Q2 2018 per CLDX's latest filing, down from $91.0 million in the prior quarter.
  • Across five years, Amortization of Goodwill topped out at $91.0 million in Q1 2018 and bottomed at -$24000.0 in Q2 2018.